top of page

Mobile monitoring for negative symptoms and cognitive impairments.

Digital phenotyping through voice and real-time assessments.

Detailed analysis of cognition and negative symptoms — alogia, blunted affect, avolition, asociality, anhedonia.

Transdiagnostic across mental health indications.


GenMind™
Co-designed with Patients and Clinicians to Enhance Access, Quality and Delivery of Mental Health Care
ABOUT
Secure by design: consent, recording, data protection.
01
Integrating voice markers with real life patient experiences.
02
Remote monitoring. Better mental healthcare access. HIPAA-compliant.
03
Dynamic patient and provider dashboards. Clear insights. No overload.
04

TECHNOLOGY
Digital biomarkers. AI-powered. Focused on cognition and negative symptoms.
01
Thousands of verbal and non-verbal features. One digital phenotype.
02
Unique user flows that adapt to each individual’s state of mind and responses.
03
Full-spectrum care for negative symptoms - from expressive to experiential deficits.
04
bottom of page








